免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

The CLASP III TR CED Study

NCT:NCT07859709 · NOT_YET_RECRUITING

NCT IDNCT07859709
狀態NOT_YET_RECRUITING
開始日期2026-10-15
完成時間2033-10-31
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated

簡要摘要

This Coverage with Evidence Development (CED) study measures the long-term health outcomes of patients with severe, symptomatic Tricuspid Regurgitation who received a Transcatheter Tricuspid Valve Repair procedure using the PASCAL Precision system.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑